Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Heparin-induced thrombocytopenia? 32 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Heparin-induced thrombocytopenia have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.0% of all adverse event reports for RIVAROXABAN.

32
Reports of Heparin-induced thrombocytopenia with RIVAROXABAN
0.0%
of all RIVAROXABAN reports
8
Deaths
15
Hospitalizations

How Dangerous Is Heparin-induced thrombocytopenia From RIVAROXABAN?

Of the 32 reports, 8 (25.0%) resulted in death, 15 (46.9%) required hospitalization, and 4 (12.5%) were considered life-threatening.

Is Heparin-induced thrombocytopenia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 32 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Heparin-induced thrombocytopenia?

HEPARIN (2,057) ENOXAPARIN (435) ARGATROBAN (91) FONDAPARINUX (76) DALTEPARIN (66) BIVALIRUDIN (61) WARFARIN (50) ASPIRIN (44) CLOPIDOGREL BISULFATE (43) APIXABAN (32)

Which RIVAROXABAN Alternatives Have Lower Heparin-induced thrombocytopenia Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Heparin-induced thrombocytopenia Reports All Drugs Causing Heparin-induced thrombocytopenia RIVAROXABAN Demographics